CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS
Clinical trials for CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection tested for stubborn lupus skin disease
Disease control Recruiting nowThis study is testing an investigational drug called IMVT-1402 for people with active cutaneous lupus, a condition causing skin rashes and lesions. About 56 participants will receive either the drug or a placebo via weekly injections for 12 weeks, followed by longer treatment per…
Matched conditions: CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial targets stubborn lupus skin rash
Disease control Recruiting nowThis study is testing an investigational drug called litifilimab for people with active skin lupus (cutaneous lupus) who haven't gotten better with standard antimalarial therapy. About 450 participants will receive either the drug or a placebo via injection every four weeks for 2…
Matched conditions: CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE2, PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC